Qualitative Estimation of Seed of Butea monosperma Lam. by using Chromatography Technique

The objective of present studies deals with the Qualitative estimation of seed of Butea monosperma Lam. By using Chromatography Technique. The phytochemical study of different extract of seed of Butea monosperma Lam. Were observed various active chemical constituent like phytosterol, flavonoid, saponin and sterol etc. Qualitative estimation of Gallic acid, Rutin and Quarcetin was carried out by HPTLC and HPLC system.

An in-vitro study of Himalayan plant extracts against oomycetes disease Saprolegniasis in rainbow trout (Oncorhynchus mykiss)

Aim: This study aimed to investigate the effectiveness of ethanolic extract of three Himalayan plants Myrica esculenta, Thymus linearis and Butea monosperma on hyphal germination, colonisation and sporulation of two species of Saprolegnia (Saprolegnia parasitica and S. australis) isolated from rainbow trout, Oncorhynchus mykiss. Molecular docking of active ingredients of M. esculenta, Myricetin with effector proteins of S. parasitica was also performed to investigate the target binding sites for drug development. Methodology: Minimum inhibitory concentration (MIC), mycelium growth inhibition, spore germination, and inhibition was performed with the most effective concentrations. Molecular docking was carried out with AutoDock Vina software to investigate target binding sites with S. parasitica. Results: Extracts from Myrica esculenta, Thymus linearis and Butea monosperma showed MIC values of the 25, 100, 50 mg ml-1 against S. parasitica and 25, 50, 25 mg ml-1 against S. australis hyphal growth, respectively. Nevertheless, malachite green as reference control was effective with a MIC value of 2.5 mg l-1. The concentration required to inhibit S. parasitica and S. australis spores were (50) Myrica esculenta, (25) Thymus linearis, (100) Butea monosperma in mg ml-1 and (50) Myrica esculenta, (50) Thymus linearis, (100) Butea monosperma in mg ml-1, respectively. Interpretation: The study concludes that M. esculenta and B. monosperma are effective against Saprolegniasis and could be used as phyto additives.

Pharmaceutical Analysis of An Anti-Diabetic Formulation: Kimshukatvagadi Ghana Capsule

Ayurveda is one of the oldest and holistic science. Herbal medicines have a long therapeutic history; serving many of the health needs of large population of the world. However, the quality control and assurance remains as a challenge due to the high discrepancy of chemical components involved. In Ayurvedic texts, several formulations have been mentioned in Prameha (Diabetes Mellitus). Kimshukatvagadi is one such formulation mentioned in Sahasrayoga Vati Prakarana adhyaya. It contains Palash (Butea monosperma Lam.), Haridra (Curcuma longa L.), Amalaki (Emblica officinalis L.), Kataka (Strychnos potatorum L.f.), Vairi (Salacia reticulata Wight). Kimshukatvagadi Vati was converted into Ghana to increase its potency and then it was sealed into Capsule for increasing the shelf life, making it easy to dispense, dose fixation etc. Kimshukatvagadi Ghana Capsule was subjected to organoleptic analysis, phytochemical and qualitative analysis to detect the presence of various functional groups, and to high performance thin layer chromatography (HPTLC) examination by optimizing the solvent systems.

A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin

Plant lectins are widely used in medical glycosciences and glycotechnology. Many lectin-based techniques have been applied for the detection of disease-associated glycans and glycoconjugates. In this study, Butea monosperma agglutinin (BMA), a lectin purified from seeds of the medicinal plant Butea monosperma, was used for the detection of cholangiocarcinoma (CCA)-associated glycans. Expression of BMA-binding N-acetyl galactosamine/galactose (GalNAc/Gal)-associated glycan (BMAG) in CCA tissues was determined using BMA lectin histochemistry; the results showed that BMAG was undetectable in normal bile ducts and drastically increased in preneoplastic bile ducts and CCA. The study in hamsters showed that an increase of BMAG was associated with carcinogenesis of CCA. Using an in-house double BMA sandwich enzyme-linked lectin assay, BMAG was highly detected in the sera of CCA patients. The level of serum BMAG in CCA patients (N = 83) was significantly higher than non-CCA controls (N = 287) and it was applicable for diagnosis of CCA with 55.4% sensitivity, 81.9% specificity, and 76.0% accuracy. A high level of serum BMAG (≥82.5 AU/mL) was associated with unfavorable survival of CCA patients; this information suggested the potential of serum BMAG as a poor prognostic indicator of CCA. In summary, BMAG was aberrantly expressed in preneoplastic bile ducts and CCA, it was also highly detected in patient serum which potentially used as a marker for diagnosis and prognostic prediction of CCA.